from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1958c/-

LFCtreatmentdescriptionclass of inhibitor

-0.225

Amikacinug/mL Amikacintranslation

-0.266

Cap5-10ug/mL Capreomycintranslation

0.107

Rox10-50 ug/mL Roxithromycintranslation

-0.836

SM2-5 ug/mL Streptomycintranslation

-0.413

Tet5-10 ug/mL Tetracyclinetranslation

0.870

Rif0.2-5ug/mL Rifampicintranscription

0.108

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.001

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.817

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.036

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.264

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.846

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.256

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.703

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.707

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.289

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.562

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.092

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.523

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.450

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.155

KCN5-20 ug/mL Potassium cyaniderespiration

-0.688

NaN30.2-2 mM Sodium aziderespiration

-0.679

Nigericin50 uM Nigericinrespiration

0.563

TRC10-150 ug/mL Triclosanrespiration

1.253

TRZ10-25 ug/mL Thioridazinerespiration

0.285

Valinomycin0.5-10 uM Valinomycinrespiration

-1.964

ZnSO42 mM ZnSO4respiration

-0.000

menadione6-10 ug/mL Menadionerespiration

0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.948

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.019

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.924

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.456

NRP_1Non-replicating persistence stage 1dosRassociated

-1.102

Amp0.2mg/mL AmpicillincellWall

0.084

Cephalexin20-100 ug/mL CephalexincellWall

-0.558

Cerulenin0.32-5 ug/mL CerulenincellWall

0.383

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.125

EMB10-20 ug/mL EthambutolcellWall

-1.419

Eta12-40 ug/mL EthionamidecellWall

-1.700

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.389

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.330

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.732

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.149

BZA0.12 mg/mL BenzamidearomaticAmides

0.084

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.514

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.121

H2O24 mM hydrogen peroxideDNAdamaging

0.202

Levo10 ug/mL LevofloxacinDNAdamaging

0.454

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.504

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.319

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.281

UVUV-irradiationDNAdamaging

0.924

ARP41-4 ug/mL Antitubercular compound ARP4?

0.234

Antimycin12.5-50 ug/mL Antimycin A?

-0.108

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.609

PA_110-50 ug/mL Antitubercular compound PA-1?

0.696

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.622

PA8240.2-2 ug/mL PA-824?

0.422

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.377

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.371

Verapamil50 uM Verapamil?

-0.877

mercaptoethanol2 mM 2-Mercaptoethanol?

0.677

methoxatin10-20 ug/mL Methoxatin?